Shifting the lines against central nervous system disorders

« Neurological disorders: a major social challenge and a market in crucial need of therapeutic innovation »

> Governance

Franck MOUTHON - Theranexus, Chairman and CEO
Franck MOUTHON
Theranexus, Chairman and CEO
 
Mathieu CHARVÉRIAT - Theranexus, Deputy CEO
Mathieu CHARVÉRIAT
Theranexus, Deputy CEO
 
Dominique COSTANTINI - Independent director
Dominique COSTANTINI
Independent director
 
Luc-André GRANIER - Independent director
Luc-André GRANIER
Independent director
 
Florian DENIS - Auriga

Auriga,represented
by Florian DENIS
 
Celia HART - CEA-Investissement

CEA-Investissement,
represented by Celia HART
 
Gwenaël HAMON - Kreaxi
Kreaxi, represented
by Gwenaël HAMON
(non-voting member)